Page URL:

Five genes linked to triple-negative breast cancer found

13 August 2018
Appeared in BioNews 962

A study has identified five genes that are associated with an aggressive form of breast cancer.

Triple-negative breast cancers (TNBC) account for around 15 percent of all breast cancers (up to 35 percent in African-American women). They tend to have lower survival rates than other breast cancers: triple negative tumours grow faster and are more likely to recur after treatment, and because they do not have receptors for estrogen, progesterone or HER2 they do not respond to targeted therapies, limiting treatment options.

'This study is the first to establish which genes are associated with high lifetime risks of triple-negative breast cancer,' said lead author Dr Fergus Couch, a geneticist at the Mayo Clinic Cancer Centre in Rochester, Minnesota.

The study – published in the Journal of the National Cancer Institute – included over 10,000 US patients with TNBC. They were screened for a panel of up to 21 genes already known to be linked to breast cancer generally. Of those, five were shown to be strongly linked to TNBC: BRCA1 and BRCA2, as well as BARD1, PALB2, and RAD51D. The presence of certain mutations in these genes could increase the lifetime risk of breast cancer by 20 percent. Two other genes were associated with a moderate increase in TNBC risk. Results were similar among Caucasian and African-American women.

The authors hope that being able to test for increased risk of TNBC can help women access more preventative care, screening and early interventions.

'The results… should help in the clinical management of women found to have inherited mutations in these genes,' said Dr Couch.

New genes discovered that may increase risk for triple-negative breast cancer
ABC News |  6 August 2018
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Journal of the National Cancer Institute |  7 August 2018
Triple-negative: Genes associated with risk for aggressive breast cancer
Science Daily |  7 August 2018
5 August 2019 - by Dr Molly Godfrey 
A newly developed blood test can spot breast cancer relapses almost a year before they are clinically detectable...
28 August 2018 - by Dr Katie Howe 
Genome sequencing has been used to shed light on the genetic causes of breast cancer in African woman and develop a model to predict breast cancer risk...
16 July 2018 - by Jen Willows 
Cancer cells may be edited to attack tumours according to new research published in Science Translational Medicine...
11 June 2018 - by Grace O'Regan 
Chemotherapy is not necessary to treat the most common type of breast cancer in 69 percent of cases, a new study has shown...
21 May 2018 - by Christie Whitehouse 
A new study indicates that an important drug used to treat breast cancer is just as effective when the course of treatment is shortened by half.
8 May 2018 - by Dr James Heather 
Genetic testing could reveal a subset of patients with aggressive breast cancer who would benefit from a non-standard treatment, a clinical trial has found...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.